| Charmacy Pharmaceutical Co., Ltd. | 02289 | 31-May-23 | | V-Ch | | |
| Charmacy Phar | 02289 | 06-Mar-00 | 27-Jun-25 | MbNC | | Ceased to be a member of the Nomination Committee in response to amendments to the Listing Rules and the Corporate Governance Code, effective 1 July 2025. |
| Charmacy Phar | 02289 | 06-Mar-00 | 31-May-23 | Ch | | For purposes of meeting the operation management needs of the Company, strengthening the division of functions and powers, improving the corporate governance structure, and compliance with the requirement of code provision C.2.1 of the Corporate Governance Code set out in Appendix 14 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited |
| Charmacy Pharmaceutical Co., Ltd. | 02289 | 25-May-15 | 31-May-23 | Ch, CEO | | |
| Charmacy Pharmaceutical Co., Ltd. | 02289 | 06-Mar-00 | 25-May-15 | ED | | |
